Sort
48,018 grants matching “immunotherapy”
T Cell Costimulatory Pathways: Functions and Interactions
$2,582,651Arlene H Sharpe · Harvard Medical School · P01 · FY2019 · AI
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,582,338Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2021 · CA
Transforming Human Pancreatic Cancer Into An Immunologic Disease
$2,582,338Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2025 · CA
Spatiotemporal regulation of T cell fate decisions in cancer
$2,578,500Andrea Schietinger · Sloan-Kettering Inst Can Research · DP2 · FY2017 · CA
Molecular and Cellular Determinants of Disease Heterogeneity in COPD
$2,578,270Frank C. Sciurba · University Of Pittsburgh At Pittsburgh · P50 · FY2012 · HL
Novel Cord Blood-Derived Cellular Therapies
$2,576,646Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2020 · CA
Case Clinical Trials Unit
$2,575,678Jeffrey M Jacobson · Case Western Reserve University · UM1 · FY2021 · AI
ETIB Clinical Research Core
$2,575,229Ronald Gress · Division Of Basic Sciences - Nci · ZID · FY2012 · CA
Combination Therapies to Defeat Melanoma Resistance
$2,574,738Antoni Ribas · University Of California Los Angeles · P01 · FY2020 · CA
University of Virginia Cancer Center Support Grant
$2,574,504Thomas P Loughran · University Of Virginia · P30 · FY2017 · CA
Precision Medicine of Cancer
$2,570,099Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Molecular and Cellular Determinants of Disease Heterogeneity in COPD
$2,569,890Frank C. Sciurba · University Of Pittsburgh At Pittsburgh · P50 · FY2010 · HL
Targeting checkpoint inhibitors for pain control
$2,569,851Ru-Rong Ji · Duke University · RF1 · FY2023 · NS
Novel Cord Blood-Derived Cellular Therapies
$2,569,848Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2021 · CA
Pacific Ovarian Cancer Research Consortium
$2,569,764Fred Hutchinson Cancer Research Center · P50 · FY2005 · CA
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
$2,564,339James R. Heath · Institute For Systems Biology · U54 · FY2025 · CA
Epigenetic basis and therapeutic targeting of the unique lymphoma immunological niche
$2,561,215Leandro C Cerchietti · Weill Medical Coll Of Cornell Univ · P01 · FY2024 · CA
Allogeneic and Autologous Immunotherapy for cancer and nonmalignant hematological disorders
$2,561,153Richard Childs · National Heart, Lung, And Blood Institute · ZIA · FY2015 · HL
Search for the Structural Basis of Biomacromolecular Function and Activity
$2,560,874Yun Xing M Wang · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Adhesion Molecules in Transfusion Biology
$2,558,031Denisa D Wagner · Immune Disease Institute, Inc. · P01 · FY2009 · HL
Combination Therapies to Defeat Melanoma Resistance
$2,556,789Antoni Ribas · University Of California Los Angeles · P01 · FY2023 · CA
Combination Therapies to Defeat Melanoma Resistance
$2,556,789Antoni Ribas · University Of California Los Angeles · P01 · FY2022 · CA
Immunobiology and Immune Therapyfor Merkel Cell Carcinoma
$2,556,762Paul Nghiem · University Of Washington · P01 · FY2023 · CA
Novel Cord Blood-Derived Cellular Therapies
$2,549,929Elizabeth J Shpall · University Of Tx Md Anderson Can Ctr · P01 · FY2022 · CA
DNA Sequencing and FACS Core Facilities
$2,549,754Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA